Published in Dement Geriatr Cogn Disord on July 20, 2011
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement (2013) 2.32
Activities of daily living: where do they fit in the diagnosis of Alzheimer's disease? Neurodegener Dis Manag (2012) 1.08
Regional cortical thinning and cerebrospinal biomarkers predict worsening daily functioning across the Alzheimer's disease spectrum. J Alzheimers Dis (2014) 0.96
CSF biomarkers of Alzheimer disease: "noncognitive" outcomes. Neurology (2013) 0.88
The default mode network may be the key substrate of depressive symptom-related cognitive changes. J Alzheimers Dis (2013) 0.87
Everyday cognition scale items that best discriminate between and predict progression from clinically normal to mild cognitive impairment. Curr Alzheimer Res (2014) 0.84
Apathy is associated with increased amyloid burden in mild cognitive impairment. J Neuropsychiatry Clin Neurosci (2013) 0.83
Self-rated and informant-rated everyday function in comparison to objective markers of Alzheimer's disease. Alzheimers Dement (2014) 0.83
Back propagation artificial neural network for community Alzheimer's disease screening in China. Neural Regen Res (2013) 0.79
SIST-M-IR activities of daily living items that best discriminate clinically normal elderly from those with mild cognitive impairment. Curr Alzheimer Res (2014) 0.79
Mild cognitive impairment is associated with poorer decision-making in community-based older persons. J Am Geriatr Soc (2015) 0.77
Functional Activities Questionnaire Items that Best Discriminate and Predict Progression from Clinically Normal to Mild Cognitive Impairment. Curr Alzheimer Res (2015) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage (2002) 49.90
The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology (1993) 47.72
Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res (1983) 41.26
Mild cognitive impairment as a diagnostic entity. J Intern Med (2004) 26.95
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol (2004) 21.56
[11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology (2006) 12.10
Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer's disease. J Neurosci (2009) 12.05
Measurement of functional activities in older adults in the community. J Gerontol (1982) 10.07
11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. Brain (2008) 9.64
Imaging beta-amyloid burden in aging and dementia. Neurology (2007) 7.70
The Alzheimer's disease neuroimaging initiative. Neuroimaging Clin N Am (2005) 7.26
Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron (2009) 7.02
Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. J Cereb Blood Flow Metab (2005) 6.25
Neuropathologic features of amnestic mild cognitive impairment. Arch Neurol (2006) 6.20
Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology (2005) 5.76
Two-year follow-up of amyloid deposition in patients with Alzheimer's disease. Brain (2006) 5.42
Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. J Med Chem (2003) 5.34
Pathological verification of ischemic score in differentiation of dementias. Ann Neurol (1980) 5.25
Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis. J Nucl Med (2005) 5.10
Dementia: the estimation of premorbid intelligence levels using the New Adult Reading Test. Cortex (1978) 4.78
Disruption of functional connectivity in clinically normal older adults harboring amyloid burden. J Neurosci (2009) 4.50
PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiol Aging (2007) 4.47
Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol (2007) 4.11
Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study. Neurology (2006) 4.06
Cognition, reserve, and amyloid deposition in normal aging. Ann Neurol (2010) 3.64
Imaging amyloid deposition in Lewy body diseases. Neurology (2008) 3.09
Amyloid imaging in mild cognitive impairment subtypes. Ann Neurol (2009) 2.66
PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment. Neurology (2007) 2.63
Amyloid-β associated cortical thinning in clinically normal elderly. Ann Neurol (2011) 2.57
Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden. Brain (2010) 1.86
Incidence of dementia in a community-dwelling Brazilian population. Alzheimer Dis Assoc Disord (2004) 1.21
Neuropathologic correlates of activities of daily living in Alzheimer disease. Alzheimer Dis Assoc Disord (2006) 1.00
Cerebral metabolic correlates of four dementia scales in Alzheimer's disease. J Neurol (2005) 0.97
Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med (2012) 14.14
Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer's disease. J Neurosci (2009) 12.05
Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron (2009) 7.02
Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 6.84
The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex (2008) 5.36
Medial temporal lobe function and structure in mild cognitive impairment. Ann Neurol (2004) 4.89
Disruption of functional connectivity in clinically normal older adults harboring amyloid burden. J Neurosci (2009) 4.50
Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis. J Neurosci (2006) 4.14
Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol (2007) 4.11
Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. J Neurosci (2007) 3.91
Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report. Arch Neurol (2007) 3.83
Cognition, reserve, and amyloid deposition in normal aging. Ann Neurol (2010) 3.64
Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study. Lancet Neurol (2012) 3.48
Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease. Arch Neurol (2011) 2.81
Functional alterations in memory networks in early Alzheimer's disease. Neuromolecular Med (2010) 2.77
Age-related memory impairment associated with loss of parietal deactivation but preserved hippocampal activation. Proc Natl Acad Sci U S A (2008) 2.65
Amyloid-β associated cortical thinning in clinically normal elderly. Ann Neurol (2011) 2.57
CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology. Nat Neurosci (2013) 2.51
Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease. Alzheimers Res Ther (2011) 2.51
The A4 study: stopping AD before symptoms begin? Sci Transl Med (2014) 2.43
Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study. Neurology (2012) 2.26
A TREM1 variant alters the accumulation of Alzheimer-related amyloid pathology. Ann Neurol (2015) 2.16
Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network. Clin Investig (Lond) (2012) 1.90
Subjective cognitive complaints and amyloid burden in cognitively normal older individuals. Neuropsychologia (2012) 1.90
Neuronal dysfunction and disconnection of cortical hubs in non-demented subjects with elevated amyloid burden. Brain (2011) 1.89
Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment. Arch Gen Psychiatry (2007) 1.88
Brain amyloid and cognition in Lewy body diseases. Mov Disord (2012) 1.87
Stepwise connectivity of the modal cortex reveals the multimodal organization of the human brain. J Neurosci (2012) 1.82
Functional abnormalities of the medial temporal lobe memory system in mild cognitive impairment and Alzheimer's disease: insights from functional MRI studies. Neuropsychologia (2007) 1.81
The dynamics of cortical and hippocampal atrophy in Alzheimer disease. Arch Neurol (2011) 1.79
Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging. Alzheimers Dement (2013) 1.77
Imaging markers for Alzheimer disease: which vs how. Neurology (2013) 1.76
Cognitive profile of amyloid burden and white matter hyperintensities in cognitively normal older adults. J Neurosci (2012) 1.76
Detection of isolated cerebrovascular beta-amyloid with Pittsburgh compound B. Ann Neurol (2008) 1.74
Understanding metamemory: neural correlates of the cognitive process and subjective level of confidence in recognition memory. Neuroimage (2005) 1.73
Selective disruption of the cerebral neocortex in Alzheimer's disease. PLoS One (2010) 1.65
Transferable, multiple antibiotic and mercury resistance in Atlantic Canadian isolates of Aeromonas salmonicida subsp. salmonicida is associated with carriage of an IncA/C plasmid similar to the Salmonella enterica plasmid pSN254. J Antimicrob Chemother (2008) 1.62
Face-name associative memory performance is related to amyloid burden in normal elderly. Neuropsychologia (2011) 1.60
Large-scale functional brain network abnormalities in Alzheimer's disease: insights from functional neuroimaging. Behav Neurol (2009) 1.58
Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer's disease. NeuroRx (2005) 1.58
Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease. Proc Natl Acad Sci U S A (2013) 1.58
Intrinsic connectivity between the hippocampus and posteromedial cortex predicts memory performance in cognitively intact older individuals. Neuroimage (2010) 1.57
Age-related differences in novelty and target processing among cognitively high performing adults. Neurobiol Aging (2004) 1.55
Evidence for a specific role of the anterior hippocampal region in successful associative encoding. Hippocampus (2007) 1.55
Executive function and instrumental activities of daily living in mild cognitive impairment and Alzheimer's disease. Alzheimers Dement (2011) 1.54
Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia. Trends Neurosci (2011) 1.51
Spatial relation between microbleeds and amyloid deposits in amyloid angiopathy. Ann Neurol (2010) 1.50
Specific subjective memory complaints in older persons may indicate poor cognitive function. J Am Geriatr Soc (2011) 1.50
Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease. Neurobiol Aging (2012) 1.49
Amyloid-β--associated clinical decline occurs only in the presence of elevated P-tau. Arch Neurol (2012) 1.48
Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease. Sci Transl Med (2014) 1.45
Amyloid deposition detected with florbetapir F 18 ((18)F-AV-45) is related to lower episodic memory performance in clinically normal older individuals. Neurobiol Aging (2012) 1.43
Conceptual and measurement challenges in research on cognitive reserve. J Int Neuropsychol Soc (2011) 1.43
Use of IQ-adjusted norms to predict progressive cognitive decline in highly intelligent older individuals. Neuropsychology (2004) 1.38
Can we prevent Alzheimer's disease? Secondary "prevention" trials in Alzheimer's disease. Alzheimers Dement (2013) 1.38
Brain imaging in Alzheimer disease. Cold Spring Harb Perspect Med (2012) 1.37
Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia. Neurology (2012) 1.33
Predicting sites of new hemorrhage with amyloid imaging in cerebral amyloid angiopathy. Neurology (2012) 1.29
A single ascending dose study of bapineuzumab in patients with Alzheimer disease. Alzheimer Dis Assoc Disord (2010) 1.29
Interim Guidelines for the Evaluation and Testing of Infants with Possible Congenital Zika Virus Infection - United States, 2016. MMWR Morb Mortal Wkly Rep (2016) 1.29
A life course model of cognitive activities, socioeconomic status, education, reading ability, and cognition. J Am Geriatr Soc (2011) 1.27
Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography/magnetic resonance imaging study. Ann Neurol (2013) 1.27
Hippocampal and neocortical activation during repetitive encoding in older persons. Neurobiol Aging (2005) 1.25
Preclinical Alzheimer disease-the challenges ahead. Nat Rev Neurol (2012) 1.25
Impaired medial temporal repetition suppression is related to failure of parietal deactivation in Alzheimer disease. Am J Geriatr Psychiatry (2008) 1.24
The parahippocampal gyrus links the default-mode cortical network with the medial temporal lobe memory system. Hum Brain Mapp (2013) 1.24